公司并购活动日益广泛。以专利为主包括具有所有权的技术信息的知识产权在公司中的价值不断攀升。有关生物医药公司的并购和投资活动日益增多。为了减少风险 ,提高投资效益 ,并购和投资前应该对有关的知识产权进行详细、周密的调查。本文以生物医药技术专利为例 ,阐述并购调查中应该考虑的几个重点事项 Corporate mergers and acquisitions are becoming increasingly widespread. Patent-based intellectual property, which includes proprietary technical information, continues to rise in value. M&A and investment activities related to biopharmaceutical companies are increasing. In order to reduce risks and increase investment returns, detailed and thorough investigations of relevant intellectual property rights should be conducted before acquisitions and investments. This article takes patents for biomedical technology as examples to illustrate several key issues that should be considered in mergers and acquisitions investigations.